ASSESSMENT OF THYROID HORMONE ABNORMALITIES IN PATIENTS OF DOWN SYNDROME

M. Siddiqui, W. Iqbal, M. Rana, M. Sufiyan, Fsm Saleem, R. Pervaiz
{"title":"ASSESSMENT OF THYROID HORMONE ABNORMALITIES IN PATIENTS OF DOWN SYNDROME","authors":"M. Siddiqui, W. Iqbal, M. Rana, M. Sufiyan, Fsm Saleem, R. Pervaiz","doi":"10.54112/pjicm.v2i1.14","DOIUrl":null,"url":null,"abstract":"Down syndrome is the fourth most come syndrome caused by chromosomal abnormalities. This syndrome includes many abnormalities such as thyroid hormone disfunction. The current study was designed to determine the prevalence of thyroid dysfunction in clinically diagnosed cases of Down syndrome patients that were confirmed on karyotyping later before including in the study. This Cross-sectional study was carried out at different Hospitals of Lahore to find out the prevalence of thyroid hormone dysfunction in 50 clinically diagnosed Down syndrome (DS) subjects from September 2019 to May 2021 by measuring thyroid function test (T3, T4, TSH), and antithyroid antibodies (ATA). A total 50 Down syndrome cases were included in the study and found majority of the patients were males 33(66.0%) while 17(34.0%) were female. Thyroid dysfunction was found in 27 (54%) of DS subjects, of whom 13 (26.0%) had hypothyroidism, 08 (16.0%) were having subclinical hypothyroidism, 01 (2.0%) had sick thyroid syndrome, 4 (8.0%) were hyperthyroidism and 01 (2.0%) were subclinical hyperthyroidism. ATA was positive in 07 (14.0%) patients of DS, of whom 02 (28%) were male and 05 were female (72%), 03 had hypothyroidism, 02 had hyperthyroidism, 02 had subclinical hypothyroidism. remaining 23 (46.0%) were having euthyroid status. This study showed 54% of down syndrome patients that were clinically diagnosed had thyroid hormone dysfunction. It can be concluded that thyroid hormone dysfunction in found in high prevalence in DS patients.","PeriodicalId":353986,"journal":{"name":"Pakistan Journal of Intensive Care Medicine","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan Journal of Intensive Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54112/pjicm.v2i1.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Down syndrome is the fourth most come syndrome caused by chromosomal abnormalities. This syndrome includes many abnormalities such as thyroid hormone disfunction. The current study was designed to determine the prevalence of thyroid dysfunction in clinically diagnosed cases of Down syndrome patients that were confirmed on karyotyping later before including in the study. This Cross-sectional study was carried out at different Hospitals of Lahore to find out the prevalence of thyroid hormone dysfunction in 50 clinically diagnosed Down syndrome (DS) subjects from September 2019 to May 2021 by measuring thyroid function test (T3, T4, TSH), and antithyroid antibodies (ATA). A total 50 Down syndrome cases were included in the study and found majority of the patients were males 33(66.0%) while 17(34.0%) were female. Thyroid dysfunction was found in 27 (54%) of DS subjects, of whom 13 (26.0%) had hypothyroidism, 08 (16.0%) were having subclinical hypothyroidism, 01 (2.0%) had sick thyroid syndrome, 4 (8.0%) were hyperthyroidism and 01 (2.0%) were subclinical hyperthyroidism. ATA was positive in 07 (14.0%) patients of DS, of whom 02 (28%) were male and 05 were female (72%), 03 had hypothyroidism, 02 had hyperthyroidism, 02 had subclinical hypothyroidism. remaining 23 (46.0%) were having euthyroid status. This study showed 54% of down syndrome patients that were clinically diagnosed had thyroid hormone dysfunction. It can be concluded that thyroid hormone dysfunction in found in high prevalence in DS patients.
唐氏综合征患者甲状腺激素异常的评估
唐氏综合症是由染色体异常引起的第四大常见综合症。这种综合征包括许多异常,如甲状腺激素功能障碍。本研究旨在确定临床诊断的唐氏综合征患者中甲状腺功能障碍的患病率,这些患者在纳入本研究之前经过核型分析确认。本横断面研究于2019年9月至2021年5月在拉合尔不同医院开展,通过测量甲状腺功能测试(T3、T4、TSH)和抗甲状腺抗体(ATA),了解50名临床诊断为唐氏综合征(DS)的患者甲状腺激素功能障碍的患病率。本研究共纳入50例唐氏综合征患者,其中男性33例(66.0%),女性17例(34.0%)。甲状腺功能障碍27例(54%),其中甲状腺功能减退13例(26.0%),亚临床甲状腺功能减退08例(16.0%),病态甲状腺综合征01例(2.0%),甲状腺功能亢进4例(8.0%),亚临床甲状腺功能亢进01例(2.0%)。DS患者ATA阳性07例(14.0%),其中男性02例(28%),女性05例(72%),甲状腺功能减退03例,甲状腺功能亢进02例,亚临床甲状腺功能减退02例。其余23例(46.0%)甲状腺功能正常。本研究显示临床上诊断的唐氏综合征患者中有54%存在甲状腺激素功能障碍。由此可见,甲状腺激素功能障碍在退行性椎体滑移患者中发病率较高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信